DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/h3j4jn/streptococcus) has announced the addition of Global Markets Direct's new report "Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H2 2012" to their offering.
“Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H2 2012”
'Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections.
Scope
- A snapshot of the global therapeutic scenario for Streptococcus Pneumoniae (Pneumococcus) Infections.
- A review of the Streptococcus Pneumoniae (Pneumococcus) Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Streptococcus Pneumoniae (Pneumococcus) Infections pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Companies Involved in Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics Development
- GlaxoSmithKline plc
- Daiichi Sankyo Company, Ltd
- Merck & Co., Inc.
- Dainippon Sumitomo Pharma Co., Ltd.
- ACE BioSciences A/S
- Intercell AG
- SIGA Technologies, Inc.
- Panacea Biotec Limited
- Eurocine Vaccines AB
- China National Biotec Group
- Mucosis B.V.
- GlycoVaxyn AG
- Aquapharm Biodiscovery Limited
- aRigen Pharmaceuticals, Inc.
- Nabriva Therapeutics AG
- Sinovac Biotech Ltd.
- Genocea Biosciences, Inc.
- NasVax Ltd.
- Morphochem AG
For more information visit http://www.researchandmarkets.com/research/h3j4jn/streptococcus
Source: Global Markets Direct





